Cepheid Gets Health Canada License For Four-in-one Rapid Molecular Diagnostic Test - Quick Facts

By RTTNews4 days ago


Cepheid, a unit of Danaher Corp. (DHR), said Thursday that it has received a medical device license from Health Canada for Xpert Xpress SARS-CoV-2/Flu/RSV, a rapid molecular diagnostic test for qualitative detection of the viruses causing COVID-19, Flu A, Flu B, and RSV infections from a single patient sample.

Continue read on rttnews.com